全文获取类型
收费全文 | 136284篇 |
免费 | 46568篇 |
国内免费 | 4649篇 |
专业分类
耳鼻咽喉 | 1866篇 |
儿科学 | 4991篇 |
妇产科学 | 1212篇 |
基础医学 | 22415篇 |
口腔科学 | 6100篇 |
临床医学 | 20236篇 |
内科学 | 31700篇 |
皮肤病学 | 7926篇 |
神经病学 | 15787篇 |
特种医学 | 4492篇 |
外国民族医学 | 40篇 |
外科学 | 20072篇 |
综合类 | 10841篇 |
现状与发展 | 15篇 |
一般理论 | 27篇 |
预防医学 | 8228篇 |
眼科学 | 2771篇 |
药学 | 12028篇 |
59篇 | |
中国医学 | 4575篇 |
肿瘤学 | 12120篇 |
出版年
2024年 | 251篇 |
2023年 | 1129篇 |
2022年 | 2716篇 |
2021年 | 4583篇 |
2020年 | 7339篇 |
2019年 | 12683篇 |
2018年 | 11975篇 |
2017年 | 13220篇 |
2016年 | 13781篇 |
2015年 | 14499篇 |
2014年 | 15019篇 |
2013年 | 15148篇 |
2012年 | 8216篇 |
2011年 | 8812篇 |
2010年 | 11805篇 |
2009年 | 7548篇 |
2008年 | 5015篇 |
2007年 | 4051篇 |
2006年 | 3912篇 |
2005年 | 3584篇 |
2004年 | 2843篇 |
2003年 | 2870篇 |
2002年 | 2674篇 |
2001年 | 2412篇 |
2000年 | 2232篇 |
1999年 | 1737篇 |
1998年 | 897篇 |
1997年 | 972篇 |
1996年 | 696篇 |
1995年 | 644篇 |
1994年 | 563篇 |
1993年 | 369篇 |
1992年 | 464篇 |
1991年 | 441篇 |
1990年 | 419篇 |
1989年 | 347篇 |
1988年 | 283篇 |
1987年 | 255篇 |
1986年 | 240篇 |
1985年 | 167篇 |
1984年 | 121篇 |
1983年 | 66篇 |
1982年 | 44篇 |
1981年 | 40篇 |
1980年 | 38篇 |
1979年 | 65篇 |
1978年 | 33篇 |
1975年 | 33篇 |
1974年 | 41篇 |
1973年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Hyun Jong Choi Jong Ho Moon Yun Nah Lee Hyun Su Kim Ji Su Ha Tae Hoon Lee Sang‐Woo Cha Young Deok Cho Sang‐Heum Park 《Digestive endoscopy》2015,27(7):772-775
Direct peroral cholangioscopy (POC) using an ultra‐slim upper endoscope is one modality of POC for intraductal endoscopic evaluation and treatment of the bile duct. Choledochoduodenostomy (CDS) is one modality of biliary bypass surgery that provides a new route to the bile duct. We carried out direct POC using an ultra‐slim upper endoscope without the use of accessories in 10 patients (four sump syndromes, three bile duct strictures and three intrahepatic duct stones) previously undergoing surgical CDS. Direct POC was successful in all patients. The use of an intraductal balloon catheter was required in one patient for advancement of the endoscope into the bile duct. Distal bile ducts with sump syndromes were cleared using baskets and water irrigation under direct POC. Cholangiocarcinoma was diagnosed in one patient with hilar bile duct stricture after cholangioscopic evaluation and a targeting forceps biopsy under direct POC. Intrahepatic duct stones were successfully extracted after intraductal fragmentation under direct POC. Oozing bleeding occurred during intraductal lithotripsy but stopped spontaneously. Direct POC using an ultra‐slim upper endoscope without the assistance of accessories can easily be carried out in patients undergoing CDS. 相似文献
3.
4.
Well‐being,health and fitness of children who use wheelchairs: Feasibility study protocol to develop child‐centred ‘keep‐fit’ exercise interventions 下载免费PDF全文
5.
Interprofessional collaboration and communication in nursing homes: a qualitative exploration of problems in medical care for nursing home residents – study protocol 下载免费PDF全文
6.
7.
8.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
9.
10.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies 下载免费PDF全文
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献